- Home
- TSQ vs CUE Comparison
TSQ vs CUE Comparison
Compare TSQ & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TSQ | CUE |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.4M | 124.5M |
| IPO Year | 2014 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TSQ | CUE |
|---|---|---|
| Price | $6.75 | $27.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $11.50 | ★ $120.00 |
| AVG Volume (30 Days) | 57.4K | ★ 115.0K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | ★ 12.80% | N/A |
| EPS Growth | ★ 69.78 | 61.11 |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $427,380,000.00 | $27,466,000.00 |
| Revenue This Year | $2.22 | N/A |
| Revenue Next Year | $0.48 | N/A |
| P/E Ratio | $42.50 | ★ N/A |
| Revenue Growth | N/A | ★ 195.75 |
| 52 Week Low | $4.30 | $0.17 |
| 52 Week High | $8.79 | $45.50 |
Technical Indicators
Market Signals| Indicator | TSQ | CUE |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 46.44 |
| Support Level | $6.47 | $23.88 |
| Resistance Level | $7.26 | $32.82 |
| Average True Range (ATR) | 0.37 | 4.41 |
| MACD | -0.03 | -0.59 |
| Stochastic Oscillator | 39.16 | 13.25 |
Price Performance
Historical ComparisonAbout TSQ Townsquare Media Inc.
Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.